GEN Exclusives

More »

GEN News Highlights

More »
Sep 23, 2008

Invitrogen Initiates Stem Cell Culture Service

  • Invitrogen introduced its PD-Direct® Bioprocess Services optimized for clinically compliant stem cell culture systems. It will help stem cell therapy developers reduce risks through serum-free production systems, improve manufacturing productivity, and provide on-demand expertise in stem cell media development, according to the firm.

    The science of each stem cell type is different and complex, and off-the-shelf products may not enable therapeutic developers to achieve their goals without significant additional investment, Invitrogen points out.

    PD-Direct® stem cell culture services provide identification of substrates and enzymes that support cell growth and passaging, determination of cell nutritional and supplementation needs, optimization of complete media formulations for key performance and cell characteristics, IP management strategies, design of formulations for clinical compliance and supply chain risk mitigation, as well as transfer to GMP formulation and manufacturing.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?